Biotechnology Stocks II Performance Guide: Entrada Therapeutics, Inc. (TRDA)
TRDA has no dividends.
Table and Chart of TRDA Performance
See what a $1,000 investment in TRDA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TRDA Returns | |
|---|---|
| Start Date | Nov-30-2021 |
| Start Price | $29.78 |
| End Date | May-16-2024 |
| End Price | $14.95 |
| # Prices | 31 |
| Min Date | Apr-29-2022 |
| Min Price | $5.98 |
| Max Date | Nov-30-2021 |
| Max Price | $29.78 |
| Total Return | -49.80% |
| Annualized Return | -23.41% |
| Current Value of $1,000 Purchase | $502 |
| Number Returns | 465 |
| Average Return | 14.12% |
| Number Profitable Returns | 267 |
| Percent Profitable Returns | 57.42% |
| Number Unprofitable Returns | 198 |
| Percent Unprofitable Returns | 42.58% |
| Profitable to Unprofitable Returns Ratio | 1.35 |
| TRDA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $489,168,000 |
| Beta | -0.386 | Price to Sales | 3.37 |
| Earnings per Share | $0.6900 |
| PE Ratio | 21 |
| PE to Growth Ratio | None |
| Price to Book | 1.797 |
| PRICE DATA | |
| 52 Week High | $18.44 |
| 52 Week Low | $10.62 |
| Analyst Target Price | $21 |
| 50-Day Moving Average | $13.13 |
| 200-Day Moving Average | $14.44 |
| FINANCIAL DATA | |
| Revenue per Share | $4.887 |
| Revenue | $162,873,000 |
| Profit Margin | 14.4% |
| Return on Equity | 9.41% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TRDA Compare Returns with S&P 500
TRDA Trendline Chart
TRDA Moving Average Chart
TRDA Stock Return Map - See Patterns of Gains and Losses
TRDA Stock Returns/Purchase Dates